Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease
Derek D. Satre,Dhweeja Dasarathy,Steven L. Batki,Michael J. Ostacher,Hannah R. Snyder,William Hua,Priti Parekh,Amy M. Shui,Ramsey Cheung,Alexander Monto,Robert J. Wong,Jennifer Y. Chen,Meimei Liao,Michele Tana,Po‐Hung Chen,Christina G. Haight,Taylor Fakadej,Mandana Khalili
DOI: https://doi.org/10.1111/apt.18387
IF: 9.524
2024-11-13
Alimentary Pharmacology & Therapeutics
Abstract:Background and Aims Alcohol use is prevalent among hepatology clinic patients with chronic liver disease (CLD). We explored factors associated with the importance and confidence dimensions of motivation to reduce drinking. Methods Participants (N = 121) with unhealthy alcohol use (i.e., over NIH guidelines) receiving care in hepatology clinics from a safety‐net hospital (SN, N = 54) and two Veterans Affairs Healthcare Systems (VA, N = 67) were enrolled in an alcohol intervention trial from March 2022 through October 2023. Baseline assessments included Generalised Anxiety Disorder (GAD‐7), Patient Health Questionnaire (PHQ‐8), Alcohol Use Disorders Identification Test (AUDIT), COVID‐19 stress; and measures of importance and confidence to decrease alcohol use (readiness rulers, scales of 1–10). Liver disease aetiology and severity were extracted from electronic health records. We performed multivariable linear regression models with forward selection to assess pre‐specified variables' associations with importance and confidence. Results The sample was 84% male, 40% Latino, 31% White, 18% Black and 11% other races; median age was 61 years. Median (Q1–Q3) AUDIT score was 16 (12–24), importance was 9 (6–10) and confidence was 8 (5–9). On multivariable analysis, VA site (vs. SN) participants had a 0.97‐point lower importance score (p = 0.02); higher symptoms of depression (PHQ‐8 score ≥ 10 vs.
pharmacology & pharmacy,gastroenterology & hepatology